Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive and Nonradioactive

Technetium-99m (Tc-99m) pertechnetate (TcO4) imaging with cyclotron produced Tc-99m compared with generator Tc-99m

Alexander McEwan, Steven McQuarrie, Douglas Abrams, Katherine Gagnon, John Wilson, Eric Turcotte, Brigitte Guerin and Roger Lecomte
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1487;
Alexander McEwan
1University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven McQuarrie
1University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas Abrams
1University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine Gagnon
1University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Wilson
1University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Turcotte
2University of Sherbrooke, Sherbrooke, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brigitte Guerin
2University of Sherbrooke, Sherbrooke, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Lecomte
2University of Sherbrooke, Sherbrooke, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1487

Objectives With the impending closures of the reactors in Petten and Chalk River there is a need to validate alternative sources of Tc-99m for routine clinical imaging. We have developed a GMP and GCP clinical trial to compare TcO4 produced by cyclotron (cpert) with TcO4 produced from a generator (pert) to evaluate the clinical potential of this production method replacing reactor supply.

Methods Cpert was obtained via proton irradiation of 99.27% enriched 100Mo metal powder pressed into an aluminum target plate. The 100Mo target was dissolved (30% H2O2, 60°C) and neutralized (3M (NH4)2CO3) prior to aqueous biphasic extraction chromatographic (ABEC) separation [1] and strong cation exchange (SCX) purification. Aluminum ion breakthrough , pH, and radiochemical purity) via instant thin layer chromatography (ITLC) of the recovered pertechnetate were evaluated. The extracted cpert demonstrated <2.5μg/mL aluminum ion concentration, a pH in the range of 5.0-7.0, and RHT that was typically less than 1-2% 24 hours post-extraction. Recovery times were <30 minutes from end-of-bombardment to the SCX-purified pertechnetate solution. Gpert was obtained from the central radio pharmacy. Whole body Tco4 imaging was performed using modified SNM procedure guidelines for Meckels diverticulum in 10 cpert and 20 case controlled gpert patients post thyroidectomy. Qualitative and quantitative comparisons of biodistribution were obtained by 2 blinded nm physicians.

Results No hematological or biochemical toxicity was associated with the cpert injections. Qualitative and quantitative analysis showed identical biodistribution with no features allowing differentiation of the 2 tracers. Case control comparison showed that uptake, clearance and biodistribution were identical for cpert and pert.

Conclusions Cpert is a clinically valid substitute for gpert in routine clinical imaging and offers a future route of Tco4 supply.

Research Support NRCan NISP gran

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Technetium-99m (Tc-99m) pertechnetate (TcO4) imaging with cyclotron produced Tc-99m compared with generator Tc-99m
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Technetium-99m (Tc-99m) pertechnetate (TcO4) imaging with cyclotron produced Tc-99m compared with generator Tc-99m
Alexander McEwan, Steven McQuarrie, Douglas Abrams, Katherine Gagnon, John Wilson, Eric Turcotte, Brigitte Guerin, Roger Lecomte
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1487;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Technetium-99m (Tc-99m) pertechnetate (TcO4) imaging with cyclotron produced Tc-99m compared with generator Tc-99m
Alexander McEwan, Steven McQuarrie, Douglas Abrams, Katherine Gagnon, John Wilson, Eric Turcotte, Brigitte Guerin, Roger Lecomte
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1487;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive and Nonradioactive

  • A radioactive method for assessing microbial safety of an infusion set for contrast-enhanced imaging
  • Cathepsin K inhibitors for in vivo osteoclast imaging by PET
  • Radiosynthesis of 64Cu-labelled cetuximab for clinical use
Show more Molecular Targeting Probes - Radioactive and Nonradioactive

Special MTA: Automation & Technology Development Posters

  • Automated Synthesis of [18F](2S,4R)-4-fluoroglutamine on a GE FX-N Pro Module
  • Automated radiosynthesis of (S)-[11C]LY2795050 for imaging κ-opioid receptors in nonhuman primate brain
  • Fully automated synthesis of a PET AD tau tracer [11C]PBB3
Show more Special MTA: Automation & Technology Development Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire